search icon
rsls-img

ReShape Lifesciences Inc, Common Stock

RSLS

NAQ

$4.66

-$0.34

(-6.8%)

1D
Industry: Health Care Equipment & Supplies Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$3.40M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.0661
Volume info-icon
This is the total number of shares traded during the most recent trading day.
42.34K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.35
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$4 L
$16.6 H
$4.66

About ReShape Lifesciences Inc, Common Stock

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California. more

Industry: Health Care Equipment & SuppliesSector: Health Care

Returns

Time FrameRSLSSectorS&P500
1-Week Return-4.59%0.31%-1.26%
1-Month Return-0.02%0.6%-4.16%
3-Month Return-12.9%-9.44%-0.46%
6-Month Return-64.71%-5.15%3.58%
1-Year Return-67.07%0.33%22.47%
3-Year Return-99.9%4.53%25.13%
5-Year Return-99.91%35.98%77.7%
10-Year Return-100%100.72%190.12%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue15.09M11.30M13.60M11.24M8.68M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":74.88,"profit":true},{"date":"2021-12-31","value":90.13,"profit":true},{"date":"2022-12-31","value":74.49,"profit":true},{"date":"2023-12-31","value":57.51,"profit":true}]
Cost of Revenue5.78M5.04M5.25M4.44M3.13M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":87.09,"profit":true},{"date":"2021-12-31","value":90.8,"profit":true},{"date":"2022-12-31","value":76.73,"profit":true},{"date":"2023-12-31","value":54.11,"profit":true}]
Gross Profit9.30M6.26M8.35M6.80M5.55M[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":67.3,"profit":true},{"date":"2021-12-31","value":89.72,"profit":true},{"date":"2022-12-31","value":73.1,"profit":true},{"date":"2023-12-31","value":59.62,"profit":true}]
Gross Margin61.67%55.42%61.38%60.52%63.93%[{"date":"2019-12-31","value":96.46,"profit":true},{"date":"2020-12-31","value":86.69,"profit":true},{"date":"2021-12-31","value":96.01,"profit":true},{"date":"2022-12-31","value":94.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Expenses25.19M18.72M36.10M33.88M20.19M[{"date":"2019-12-31","value":69.79,"profit":true},{"date":"2020-12-31","value":51.86,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":93.86,"profit":true},{"date":"2023-12-31","value":55.92,"profit":true}]
Operating Income(15.89M)(12.46M)(27.75M)(27.08M)(14.64M)[{"date":"2019-12-31","value":-1588700000,"profit":false},{"date":"2020-12-31","value":-1245700000,"profit":false},{"date":"2021-12-31","value":-2774900000,"profit":false},{"date":"2022-12-31","value":-2707800000,"profit":false},{"date":"2023-12-31","value":-1463900000,"profit":false}]
Total Non-Operating Income/Expense(59.66M)(11.40M)(35.12M)(4.79M)3.15M[{"date":"2019-12-31","value":-1892.29,"profit":false},{"date":"2020-12-31","value":-361.66,"profit":false},{"date":"2021-12-31","value":-1113.92,"profit":false},{"date":"2022-12-31","value":-152.05,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(75.10M)(21.81M)(62.04M)(46.59M)(11.34M)[{"date":"2019-12-31","value":-7510000000,"profit":false},{"date":"2020-12-31","value":-2181100000,"profit":false},{"date":"2021-12-31","value":-6203900000,"profit":false},{"date":"2022-12-31","value":-4659400000,"profit":false},{"date":"2023-12-31","value":-1133500000,"profit":false}]
Income Taxes(893.00K)(181.00K)(106.00K)(380.00K)52.00K[{"date":"2019-12-31","value":-1717.31,"profit":false},{"date":"2020-12-31","value":-348.08,"profit":false},{"date":"2021-12-31","value":-203.85,"profit":false},{"date":"2022-12-31","value":-730.77,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(74.21M)(21.63M)(61.93M)(46.21M)(11.39M)[{"date":"2019-12-31","value":-7420700000,"profit":false},{"date":"2020-12-31","value":-2163000000,"profit":false},{"date":"2021-12-31","value":-6193300000,"profit":false},{"date":"2022-12-31","value":-4621400000,"profit":false},{"date":"2023-12-31","value":-1138700000,"profit":false}]
Income From Continuous Operations(74.21M)(21.63M)(61.93M)(46.21M)(26.16M)[{"date":"2019-12-31","value":-7420700000,"profit":false},{"date":"2020-12-31","value":-2163000000,"profit":false},{"date":"2021-12-31","value":-6193300000,"profit":false},{"date":"2022-12-31","value":-4621400000,"profit":false},{"date":"2023-12-31","value":-2615800000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(74.21M)(21.63M)(61.93M)(46.21M)(11.39M)[{"date":"2019-12-31","value":-7420700000,"profit":false},{"date":"2020-12-31","value":-2163000000,"profit":false},{"date":"2021-12-31","value":-6193300000,"profit":false},{"date":"2022-12-31","value":-4621400000,"profit":false},{"date":"2023-12-31","value":-1138700000,"profit":false}]
EPS (Diluted)(1.10K)(238.50)(190.50)(81.59)(3.55)[{"date":"2019-12-31","value":-110250,"profit":false},{"date":"2020-12-31","value":-23850,"profit":false},{"date":"2021-12-31","value":-19050,"profit":false},{"date":"2022-12-31","value":-8159,"profit":false},{"date":"2023-12-31","value":-355,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

RSLS
Cash Ratio 0.18
Current Ratio 1.33
Quick Ratio 0.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

RSLS
ROA (LTM) -63.46%
ROE (LTM) -184.59%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

RSLS
Debt Ratio Lower is generally better. Negative is bad. 0.74
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.26

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

RSLS
Trailing PE 0.07
Forward PE NM
P/S (TTM) 0.42
P/B 2.45
Price/FCF NM
EV/R 0.38
EV/Ebitda NM

FAQs

What is ReShape Lifesciences Inc share price today?

ReShape Lifesciences Inc (RSLS) share price today is $4.66

Can Indians buy ReShape Lifesciences Inc shares?

Yes, Indians can buy shares of ReShape Lifesciences Inc (RSLS) on Vested. To buy ReShape Lifesciences Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in RSLS stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ReShape Lifesciences Inc be purchased?

Yes, you can purchase fractional shares of ReShape Lifesciences Inc (RSLS) via the Vested app. You can start investing in ReShape Lifesciences Inc (RSLS) with a minimum investment of $1.

How to invest in ReShape Lifesciences Inc shares from India?

You can invest in shares of ReShape Lifesciences Inc (RSLS) via Vested in three simple steps:

  • Click on Sign Up or Invest in RSLS stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ReShape Lifesciences Inc shares
What is ReShape Lifesciences Inc 52-week high and low stock price?

The 52-week high price of ReShape Lifesciences Inc (RSLS) is $16.6. The 52-week low price of ReShape Lifesciences Inc (RSLS) is $4.

What is ReShape Lifesciences Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of ReShape Lifesciences Inc (RSLS) is 0.0661

What is ReShape Lifesciences Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ReShape Lifesciences Inc (RSLS) is 2.45

What is ReShape Lifesciences Inc dividend yield?

The dividend yield of ReShape Lifesciences Inc (RSLS) is 0.00%

What is the Market Cap of ReShape Lifesciences Inc?

The market capitalization of ReShape Lifesciences Inc (RSLS) is $3.40M

What is ReShape Lifesciences Inc’s stock symbol?

The stock symbol (or ticker) of ReShape Lifesciences Inc is RSLS

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top